SEC Form 4Coverage since Jun 29, 2026
$ADIL insider trading
Over the last 12 months, Adial Pharmaceuticals insiders reported 3 buys totaling $106K and no sales across SEC Form 4 filings.
- Bought · 12m
- $106K 3 events
- Sold · 12m
- — 0 events
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ADIL · 12Mvia TradingView
Top insiders · 12m
Coastlands Capital LP—3× · $106K
All insider trades
3 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Coastlands Capital LP10% | ▲ Buy | 3,233 | $2.69 | $9K | +0.8% | 2 tranches · indirect |
| Jul 10, 2026 | Coastlands Capital LP10% | ▲ Buy | 11,753 | $2.78 | $33K | +3.1% | 2 tranches · indirect |
| Jun 29, 2026 | Coastlands Capital LP10% | ▲ Buy | 25,000 | $2.6 | $65K | +7.2% | indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ADIL feed.